# OnCo record paper-wallen-fludarabine-ctl-melanoma-plos-one-2009 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-wallen-fludarabine-ctl-melanoma-plos-one-2009/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-wallen-fludarabine-ctl-melanoma-plos-one-2009" ;
  schema:name "Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma"@en ;
  schema:description "A small trial in ten people with advanced melanoma that compared how long infused T cells lasted with and without the chemotherapy drug fludarabine first. Fludarabine made them last about three times longer."@en ;
  schema:url <https://onco.cc/key-papers/paper-wallen-fludarabine-ctl-melanoma-plos-one-2009/> ;
  schema:dateModified "2026-11-05"^^xsd:date ;
  schema:citation <https://doi.org/10.1371/journal.pone.0004749>, <https://pubmed.ncbi.nlm.nih.gov/19270751/>, <https://clinicaltrials.gov/study/NCT00317759> ;
  schema:sameAs <https://doi.org/10.1371/journal.pone.0004749> ;
  schema:datePublished "2009"^^xsd:gYear ;
  schema:author "Wallen H, Thompson JA, Reilly JZ, Rodmyre RM, Cao J, Yee C." ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/fludarabine/> ;
  onco:institutions <https://onco.cc/institutions/fred-hutch/> ;
  onco:terms <https://onco.cc/terms/endogenous-t-cell-therapy/>, <https://onco.cc/terms/lymphodepletion/> ;
  onco:trials <https://onco.cc/trials/nct00317759/> ;
  onco:people <https://onco.cc/people/cassian-yee/> .